You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仙樂健康(300791.SZ):收購Best Formulations股權案通過美反壟斷審查
格隆匯 08-16 08:02

格隆匯8月16日丨仙樂健康(300791.SZ)公吿稱,公司於2022年7月6日召開第三屆董事會第十次會議,審議通過了《關於收購Best Formulations Inc. 80%股權的議案》。公司及其間接全資子公司Sirio Healthcare Holdings LLC.(與公司合稱為“買方”)與Eugene C. Ung、Kelly C. Ung、Charles C. Ung、Peak TrustCompany-NV、Jeffrey A. Goh、Joy S. Hsu(合稱為“賣方”)簽訂《MEMBERSHIP INTEREST PURCHASE AGREEMENT》,買方擬向賣方收購Best Formulations Inc. 80%股權。

2022年7月12日,公司就該次交易向美國聯邦貿易委員會和司法部提交了書面的《特定合併與收購通知與報吿表》;截止2022年8月12日,反壟斷審查等待期已經結束,該次交易涉及的美國反壟斷申報事項已獲通過。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account